Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any pancreatic agenesis in which the cause of the disease is a mutation in the PDX1 gene.
Features include always present findings: Oligohydramnios, Failure to thrive, Reduced C-peptide level, and Exocrine pancreatic insufficiency and others.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Digestive system | 3 | Exocrine pancreatic insufficiency, Pancreatic hypoplasia, Pancreatic aplasia |
PDX1 function has not been fully characterized.
Pancreatic agenesis 1 is caused by mutations in the PDX1 gene on chromosome 13.
Genetic testing for PDX1 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for pancreatic agenesis 1 has been reported in the published literature.
Phenotype severity distribution: 8 always present features.
1 clinical trial registered. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
217 publications have been identified in PubMed for pancreatic agenesis 1. Research spans Basic Science / Preclinical (28%), Review / Meta-Analysis (18%), and Epidemiology / Natural History (18%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 60 | 28% |
Data assembled from 7 of 12 sources · Last updated Sep 19, 2026, 12:43 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
2 |
Failure to thrive, Intrauterine growth retardation |
Hormones | 1 | Neonatal insulin-dependent diabetes mellitus |
Pregnancy and birth | 1 | Neonatal insulin-dependent diabetes mellitus |
Age of onset: newborn period.
Research summaries |
39 |
18% |
Disease patterns and progression | 38 | 18% |
Patient case studies | 32 | 15% |
Testing and diagnosis research | 28 | 13% |
Clinical study results | 15 | 7% |
New treatment approaches | 5 | 2% |
Hara T (2026). [PMID: 41500557](https://pubmed.ncbi.nlm.nih.gov/41500557/). *Cell Struct Funct*. [Case Report / Case Series]
Wang P (2026). [PMID: 40815390](https://pubmed.ncbi.nlm.nih.gov/40815390/). *Eur J Nucl Med Mol Imaging*. [Diagnostic / Biomarker]
Suphamungmee W (2026). [PMID: 42195206](https://pubmed.ncbi.nlm.nih.gov/42195206/). *Medicina (Kaunas)*. [Review / Meta-Analysis]
Omotosho YB (2026). [PMID: 41498210](https://pubmed.ncbi.nlm.nih.gov/41498210/). *J Clin Endocrinol Metab*. [Epidemiology / Natural History]
Denson AM (2026). [PMID: 41006196](https://pubmed.ncbi.nlm.nih.gov/41006196/). *J Clin Endocrinol Metab*. [Epidemiology / Natural History]
Gagyi EB (2026). [PMID: 41381081](https://pubmed.ncbi.nlm.nih.gov/41381081/). *Clin Exp Pediatr*. [Review / Meta-Analysis]
Abinaya M (2026). [PMID: 42086843](https://pubmed.ncbi.nlm.nih.gov/42086843/). *Sci Rep*. [Case Report / Case Series]
Nakamura K (2026). [PMID: 40895517](https://pubmed.ncbi.nlm.nih.gov/40895517/). *DEN Open*. [Epidemiology / Natural History]
S'hih Y (2026). [PMID: 41872523](https://pubmed.ncbi.nlm.nih.gov/41872523/). *J Mol Histol*. [Diagnostic / Biomarker]
Kim JM (2026). [PMID: 40961229](https://pubmed.ncbi.nlm.nih.gov/40961229/). *Int J Surg*. [Epidemiology / Natural History]